Related Experiment Video
Updated: Feb 15, 2026

Author Spotlight: Integrating BRET-Based Assays and Rare Mutation Analysis to Decipher RAF Kinase Regulation in Live Cells
Published on: March 1, 2024
Chk1 and 14-3-3 proteins inhibit atypical E2Fs to prevent a permanent cell cycle arrest
Ruixue Yuan1, Harmjan R Vos2, Robert M van Es2
1Department of Pathobiology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Abstract:
The atypical E2Fs, E2F7 and E2F8, act as potent transcriptional repressors of DNA replication genes providing them with the ability to induce a permanent S-phase arrest and suppress tumorigenesis. Surprisingly in human cancer, transcript levels of atypical E2Fs are frequently elevated in proliferating cancer cells, suggesting that the tumor suppressor functions of atypical E2Fs might be inhibited through unknown post-translational mechanisms. Here, we show that atypical E2Fs can be directly phosphorylated by checkpoint kinase 1 (Chk1) to prevent a permanent cell cycle arrest. We found that 14-3-3 protein isoforms interact with both E2Fs in a Chk1-dependent manner. Strikingly, Chk1 phosphorylation and 14-3-3-binding did not relocate or degrade atypical E2Fs, but instead, 14-3-3 is recruited to E2F7/8 target gene promoters to possibly interfere with transcription. We observed that high levels of 14-3-3 strongly correlate with upregulated transcription of atypical E2F target genes in human cancer. Thus, we reveal that Chk1 and 14-3-3 proteins cooperate to inactivate the transcriptional repressor functions of atypical E2Fs. This mechanism might be of particular importance to cancer cells, since they are exposed frequently to DNA-damaging therapeutic reagents.
Insights
Checkpoint kinase 1 (Chk1) and 14-3-3 proteins inactivate atypical E2Fs, crucial for suppressing tumors. This mechanism may be vital for cancer cells facing DNA-damaging therapies.
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Biology
Background:
- Atypical E2Fs (E2F7, E2F8) normally repress DNA replication genes, inducing S-phase arrest and suppressing tumors.
- Elevated atypical E2F levels in human cancers suggest inhibited tumor suppressor functions via unknown post-translational modifications.
Purpose of the Study:
- To investigate the post-translational mechanisms regulating atypical E2F function in cancer.
- To identify how checkpoint kinase 1 (Chk1) and 14-3-3 proteins influence atypical E2Fs.
Main Methods:
- Phosphorylation assays to determine Chk1's effect on E2F7/8.
- Co-immunoprecipitation to assess 14-3-3 protein interactions with E2Fs.
- Chromatin immunoprecipitation to analyze protein binding at target gene promoters.
- Correlation analysis of 14-3-3 protein levels and target gene expression in human cancers.
Main Results:
- Chk1 directly phosphorylates atypical E2Fs, preventing permanent S-phase arrest.
- 14-3-3 proteins bind to E2Fs in a Chk1-dependent manner.
- Chk1-mediated phosphorylation and 14-3-3 binding recruit 14-3-3 to E2F7/8 target gene promoters, interfering with transcription.
- High 14-3-3 levels correlate with increased transcription of atypical E2F target genes in human cancers.
Conclusions:
- Chk1 and 14-3-3 proteins cooperate to inactivate the transcriptional repressor activity of atypical E2Fs.
- This inactivation mechanism is important for cancer cells, particularly under DNA-damaging therapeutic conditions.
- Understanding this pathway offers potential therapeutic targets for cancer treatment.
Related Concept Videos
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Piaget's Stage 3 of Cognitive Development
Conservation and Constancy of Quantity
A significant cognitive milestone in the...
Negative Regulator Molecules
Feedback Inhibition
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
What is the Cell Cycle?

